# Evaluate the Safety and Efficacy of RegenKit Autologous PRP Gel for the Treatment of Diabetic Foot Ulcer

> **NCT02402374** · NA · UNKNOWN · sponsor: **Regen Lab SA** · enrollment: 192 (estimated)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **DEVICE:** Autologous platelet rich plasma gel
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT02402374
- **Lead sponsor:** Regen Lab SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-12
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02402374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02402374, "Evaluate the Safety and Efficacy of RegenKit Autologous PRP Gel for the Treatment of Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02402374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*